Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mega-trials vs. meta-analysis: precision vs. heterogeneity?

Ian Shrier1, Robert W Platt, Russell J Steele

  • 1Centre for Clinical Epidemiology and Community Studies, SMBD-Jewish General Hospital, McGill University, 3755 Cote Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2. ian.shrier@mcgill.ca

Contemporary Clinical Trials
|December 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Re-establishing Confidence in Confidence Intervals: An Evaluation of Recent Practices in Sport Injury Epidemiology.

Sports medicine (Auckland, N.Z.)·2026
Same author

The risk of subsequent concussion in adolescent ice hockey players with ≥2 concussions.

Journal of science and medicine in sport·2026
Same author

Identification of the causal odds ratio in test negative designs.

International journal of epidemiology·2026
Same author

Unifying to Advance Understanding: Collaborative, Community-Driven and 'Open' Approaches for Better Science in Sport.

Sports medicine (Auckland, N.Z.)·2026
Same author

The interventionist approach can address questions related to causes of effects if causes are considered as states instead of interventions.

Observational studies·2026
Same author

Introducing a new "Preliminary Report" submission category for small-sample intervention studies: viewpoints from external experts.

Science & medicine in football·2026
Same journal

Are older adult research participants representative of the general population? Results from 19 clinical studies at one academic research center.

Contemporary clinical trials·2026
Same journal

Multi-site feasibility of a web-based and telephone navigation intervention to connect lung cancer caregivers in community oncology settings with resources: Protocol for the WF-2301CD caregiver oncology needs evaluation tool (CONNECT) trial.

Contemporary clinical trials·2026
Same journal

Rationale and design of a CArdiac rehabilitation program on the prevention of CardioTOXicity in breast Cancer patients undergoing treatment with anthracyclines and/or trastuzumab (CARPTOX-BC) trial: A randomized, active control group, open-label trial.

Contemporary clinical trials·2026
Same journal

Evaluating clinical outcomes of using Undermyfork mobile app with Dexcom G7: Protocol for CGM-Undermyfork randomized controlled trial.

Contemporary clinical trials·2026
Same journal

Outcomes of dyadic recruitment in the promoting re-engagement in meaningful activity (PRIMA) trial.

Contemporary clinical trials·2026
Same journal

Overview of the linking exercise for advancing daily stress (LEADS) management and resilience randomized controlled trial in African American families.

Contemporary clinical trials·2026
See all related articles

Mega-trials, or very large clinical trials, are debated against smaller, focused randomized controlled trials (RCTs). While mega-trials offer minor benefits in reducing chance confounding, smaller trials may provide advantages through inherent heterogeneity.

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Evidence-Based Medicine

Background:

  • The necessity of very large clinical trials, termed "mega-trials," for addressing complex clinical questions and subgroup analyses has been proposed.
  • Mega-trials are resource-intensive, raising concerns about diverting funds from other critical research, including smaller, focused randomized controlled trials (RCTs).

Purpose of the Study:

  • To theoretically compare the advantages and disadvantages of mega-trials versus a series of smaller RCTs.
  • To evaluate sample size requirements and the potential for confounding by chance in both approaches.

Main Methods:

  • Theoretical argumentation and comparative analysis of trial designs.
  • Examination of statistical considerations, including sample size and confounding, for mega-trials and multiple smaller RCTs.

Related Experiment Videos

Main Results:

  • Theoretical arguments suggest similar sample size requirements for both mega-trials and a series of smaller RCTs.
  • Mega-trials may offer a slight advantage in minimizing confounding by chance.
  • A series of smaller RCTs may benefit from inherent heterogeneity, potentially outweighing the advantages of a single mega-trial.

Conclusions:

  • The debate on mega-trials versus smaller RCTs requires careful consideration of resource allocation and methodological trade-offs.
  • While mega-trials present some statistical advantages, the heterogeneity inherent in multiple smaller trials could be a significant benefit for clinical research.